Soluble urokinase-plasminogen activator receptor (suPAR) and natural phosphorylcholine IgM antibodies in patients at clinical onset of diabetes mellitus

Journals Menu

Follow SCIRP

ISSN Print: 2160-5831
ISSN Online: 2160-5858
www.scirp.org/journal/jdm
E-mail: jdm@scirp.org

"Soluble urokinase-plasminogen activator receptor (suPAR) and natural phosphorylcholine IgM antibodies in patients at clinical onset of diabetes mellitus"
written by Magnus Hillman, Mona Landin-Olsson,
published by Journal of Diabetes Mellitus, Vol.1 No.4, 2011

has been cited by the following article(s):

[1]	Plasma levels of soluble urokinase plasminogen activator receptor (suPAR) and high-sensitivity C-reactive protein after Roux-en-Y gastric bypass or sleeve …
	2020

[2]	Renal Biopsy: Use of Biomarkers as a Tool for the Diagnosis of Focal Segmental Glomerulosclerosis
	Disease markers, 2014

[1]	Soluble Urokinase Plasminogen Activated Receptor in Type 2 Diabetes Mellitus Patients Undergoing Coronary Artery Bypass Grafting: A Prospective Interventional Cohort Study Journal of Cardiac Critical Care TSS, 2024 DOI:10.25259/JCCC_48_2024

[2]	Plasma levels of soluble urokinase plasminogen activator receptor (suPAR) and high-sensitivity C-reactive protein after Roux-en-Y gastric bypass or sleeve gastrectomy: a 1-year prospective observational study Journal of Endocrinological Investigation, 2020 DOI:10.1007/s40618-020-01358-7

[3]	Renal Biopsy: Use of Biomarkers as a Tool for the Diagnosis of Focal Segmental Glomerulosclerosis Disease Markers, 2014 DOI:10.1155/2014/192836

Follow SCIRP